CA
VKTX icon

Cetera Advisors’s Viking Therapeutics VKTX Stock Holding History

Cetera Advisors’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$239K Buy
+2,916
New +$130K ﹤0.01% 2094

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Cetera Advisors's VKTX Position: Q1 2024 in Review

Cetera Advisors opened a new position in Viking Therapeutics (VKTX) in Q1 2024: 2,916 shares worth $239K. The stake represents ﹤0.01% of the portfolio and ranks #2094 among its holdings.

375 funds tracked by Wall St. Rank hold VKTX as of Q1 2024.

  • Cetera Advisors held 2,916 shares of Viking Therapeutics worth $239K as of Q1 2024.
  • Viking Therapeutics was a new Cetera Advisors position in Q1 2024.
  • Viking Therapeutics made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #2094 holding.
  • 375 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.